Aug 08, 2026 — Digital Edition
Gerald Ideas
Independent Journalism & Insight
Feature

Prostate Cancer Progression and the Epigenome trends worth trying

Prostate Cancer Progression and the Epigenome

Prostate Cancer Progression and the Epigenome
Prostate Cancer Progression and the Epigenome

Prostate cancer is driven by interrelated genetic 1,2 and epigenetic 3 alterations. Known genetic contributors to sporadic prostate cancer are the presence of germline genetic variants that ...

Brucine Suppresses Malignant Progression of Prostate Cancer
Brucine Suppresses Malignant Progression of Prostate Cancer

Known genetic contributors to sporadic prostate cancer are the presence of germline genetic variants that in-crease the risk of prostate cancer and of somatic mutations, rearrangements, or ...

Prostate Cancer Epigenome

Prostate Cancer Signaling Pathway
Prostate Cancer Signaling Pathway

Abstract Prostate cancer is a major health burden within the ever-increasingly aging US population. The molecular mechanisms involved in prostate cancer are diverse and heterogeneous. In this context, epigenetic changes, both global and gene specific, are now an emerging alternate mechanism in disease initiation and progression . The three major risk factors in prostate cancer : age, geographic ...

Role of lncRNAs in prostate cancer development and progression . Weiss M, Plass C, Gerhauser C Biol Chem, 395 (11):1275-1290, 01 Nov 2014 Cited by: 19 articles | PMID: 25153594 Review

Downregulation of BKCa inhibits prostate cancer cell proliferation
Downregulation of BKCa inhibits prostate cancer cell proliferation

Interplay of the 3D genome and epigenome in androgen

Here, we present a perspective on how the spatial architecture of the epigenome , including 3D chromatin structure and dynamics, orchestrates dysregulation of transcription factor networks that help to drive disease progression in androgen-driven prostate cancer .

Epigenetic Regulation in Prostate Cancer The regulation of gene expression is critical both to normal development and to disease. Epigenetic Regulation in Prostate Cancer The regulation of gene expression is critical both to normal development and to disease. A recent study provides insight into how increased androgen-recepto...

Figure 1 from Downregulation of CAMK2N1 due to DNA Hypermethylation
Figure 1 from Downregulation of CAMK2N1 due to DNA Hypermethylation

PDF Prostate cancer epigenetics from pathophysiology to ...

Each section is structured to encompass the full spectrum of prostate cancer progression , from localized to metastatic disease, castration-resistant prostate cancer (CRPC) and neuroendocrine ...

In addition to somatic genetic alterations, deviations in the epigenetic landscape of cancer cells and their tumor microenvironment (TME) are critical drivers of prostate cancer initiation and progression .

ASB1 inhibits prostate cancer progression by destabilizing CHCHD3 via
ASB1 inhibits prostate cancer progression by destabilizing CHCHD3 via

PDF Prostate Cancer Epigenetics

Alterations in the epigenetic cityscape of pros-tatecancercellscomparedwithnormalprostatetissueshaveacomplexinterplay withgenetic alterations to drive prostate cancer initiation and progression . Indeed, mutations in genes encoding epigenetic enzymes are often observed in human cancers including prostate cancer .

Targeting Prostate Cancer The Tousled Way v2
Targeting Prostate Cancer The Tousled Way v2
Why Are Prostate Cancer Preclinical Models Hard to Develop
Why Are Prostate Cancer Preclinical Models Hard to Develop
Downregulation of SEPTIN5 inhibits prostate cancer progression
Downregulation of SEPTIN5 inhibits prostate cancer progression
Downregulation of SEPTIN5 inhibits prostate cancer progression
Downregulation of SEPTIN5 inhibits prostate cancer progression
downregulation of septin5 inhibits prostate cancer progression by
downregulation of septin5 inhibits prostate cancer progression by
RNA m6a Methylation Regulator Expression in Castration Resistant
RNA m6a Methylation Regulator Expression in Castration Resistant
PDF Downregulation of γ Catenin by miR 195 5p Inhibits Colon Cancer
PDF Downregulation of γ Catenin by miR 195 5p Inhibits Colon Cancer

Prioritizing biomarker-oriented clinical trials is essential to identify specific molecular subgroups of patients with prostate cancer who are most likely to benefit from epigenetic drugs.